| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927167A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors |
| 07/07/1999 | EP0587799B1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/06/1999 | US5919960 Phytosphingosine-based ceramide I analogs |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919826 Synergistic mixture of tramadol and asparatic acid, n-methyl-receptor antagonist |
| 07/06/1999 | US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919809 3-substituted-2-oxindole derivatives |
| 07/06/1999 | US5919805 Hetrocyclic compounds and their preparation and use |
| 07/06/1999 | US5919801 N-substituted piperidines as PDE4 inhibitors |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919775 Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
| 07/06/1999 | US5919774 Novel compounds such as 2-(1-benzyl-2,5-dimethyl-4-(2-carboxyphenylmethyl)pyrrol-3-yl) glyoxamide for inhibiting human nonpancreatic secretory phospholipase a2 (spla2) mediated release of fatty acids in a mammal |
| 07/06/1999 | US5919687 Polynucleotide coding for neutral sphingomyelinase; for screening compounds for diagnosis and treatment of diseases; antiarthritic/antitumor/anticarcinogenic/anticholesterol agents; psychological/nervous system disorders |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2017920C Beta-lactam elastase inhibitors |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032483A1 New pharmaceutically active compounds |
| 07/01/1999 | WO1999032463A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 07/01/1999 | WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032449A2 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 07/01/1999 | WO1999032433A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 07/01/1999 | WO1999032121A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032110A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | WO1999031969A2 Transgenic animal model for degenerative diseases of cartilage |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999016741A3 Lipophilic diesters of chelating agents |
| 07/01/1999 | DE19757414A1 Fettmischung Fatblend |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | CA2314980A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 07/01/1999 | CA2314357A1 Transgenic animal model for degenerative diseases of cartilage |
| 07/01/1999 | CA2300197A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926137A1 Picolin acid derivatives useful in the treatment of IL-1 and TNF mediated diseases |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925294A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/30/1999 | EP0925289A1 Matrix metalloproteinase inhibitors |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | EP0749429B1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221424A 肽衍生物 Peptide derivatives |
| 06/30/1999 | CN1221407A Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
| 06/30/1999 | CN1221403A Compounds with anti-inflammatory and immunosuppressive activities |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/29/1999 | US5917047 Heterocyclic compounds |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5916922 For inhibiting human non-pancreatic secretory phospholipase a2 |
| 06/29/1999 | US5916901 Heterocyclic compounds |
| 06/29/1999 | US5916889 1,4-disubstituted piperazines |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | US5916885 Treatment of psoriasis, dermatitis |
| 06/29/1999 | US5916878 Dipeptide of either gamma-glutamyl-l-tryptophan or beta-aspartyl-l-tryptophan; administering to the patients to reduce the risks infections from microorganism |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | US5916587 Transdermal delivery matrix for piroxicam |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999031105A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines |
| 06/24/1999 | WO1999031103A1 Preparation of 3-substituted adenines |
| 06/24/1999 | WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031092A1 Benzamine derivatives |
| 06/24/1999 | WO1999031078A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors |